Abstract
Negative-strand RNA viruses form cytoplasmic inclusion bodies (IBs) representing virus replication foci through phase separation or bio-molecular condensation of viral and cellular proteins, as a hallmark of their infection. Alternatively, mammalian cells form stalled-mRNA containing antiviral stress granules (SGs), as a consequence of phosphorylation of eukaryotic initiation factor 2α (eIF2α) through condensation of several RNA-binding proteins including TIA-1. Whether and how Chandipura virus (CHPV), an emerging human pathogen causing influenza-like illness, coma and death; forms IBs and evades antiviral SGs, remains unknown. By confocal imaging on CHPV-infected Vero-E6 cells, we found that CHPV infection doesn’t induce formation of distinct canonical SGs. Instead, CHPV proteins condense and co-localize together with SG-proteins to form heterogeneous IBs, which ensued independent of the activation of eIF2α and eIF2α Kinase, Protein Kinase R (PKR). Interestingly, siRNA-mediated depletion of PKR or TIA-1 significantly decreased viral transcription and virion production. Moreover, CHPV infection also caused condensation and recruitment of PKR to IBs. Compared to SGs, IBs exhibited significant rapidity in disassembly dynamics. Altogether, our study demonstrates that CHPV-replication co-optimizing with SG-proteins and revealing unprecedented proviral role of TIA-1/PKR, may have implication in understanding the mechanisms regulating CHPV-IB formation, and designing antiviral therapeutic.
Importance CHPV is an emerging tropical pathogen reported to cause acute influenza-like-illness and encephalitis in children with very high mortality rate of ∼70%. Lack of a vaccines and an effective therapy against CHPV makes it a potent pathogen for causing an epidemic in tropical parts of globe. Given these forewarnings, it is of paramount importance that CHPV biology must be understood comprehensively. Targeting of host factors offers several advantages over targeting the viral components due to in general higher mutation rate in viral genome. In this study, we aimed at understanding the role of those cellular RNA binding proteins in CHPV replication, which form SGs. Our study helps understand participation of cellular factors in CHPV replication and could help develop effective therapeutics against the virus.
Footnotes
Abbreviation: (Immunofluorescence assay; IFA, T-cell intracellular antigen; TIA-1, Poly A binding protein; PABP, Argonaute −2; Ago2, RasGTPase-activating protein-binding protein 1; G3BP1, eukaryotic initiation factor 3 eta; eIF3η, eukaryotic initiation factor 2 alpha; eIF2α, interferon inducible protein kinase R; PKR, Stress granule proteins; SGPs, Lipid droplets; LDs)